Literature DB >> 23529912

In vitro biological response of plasma electrolytically oxidized and plasma-sprayed hydroxyapatite coatings on Ti-6Al-4V alloy.

Wing Kiu Yeung1, Gwendolen C Reilly, Allan Matthews, Aleksey Yerokhin.   

Abstract

Plasma electrolytic oxidation (PEO) is a relatively new surface modification process that may be used as an alternative to plasma spraying methods to confer bioactivity to Ti alloy implants. The aim of this study was to compare physical, chemical and biological surface characteristics of two coatings applied by PEO processes, containing different calcium phosphate (CaP) and titanium dioxide phases, with a plasma-sprayed hydroxyapatite (HA) coating. Coating characteristics were examined by X-ray diffraction, energy dispersive X-ray spectroscopy, scanning electron microscopy, surface profilometry, and wettability tests. The biological properties were determined using the human osteoblastic cell line MG-63 to assess cell viability, calcium and collagen synthesis. The tests showed that PEO coatings are significantly more hydrophilic (6%) and have 78% lower surface roughness (Ra) than the plasma-sprayed coatings. Cell behavior was demonstrated to be strongly dependent on the phase composition and surface distribution of elements in the PEO coating. MG-63 viability for the TiO2 -based PEO coating containing amorphous CaPs was significantly lower than that for the PEO coating containing crystalline HA and the plasma-sprayed coating. However, collagen synthesis on both the CaP and the TiO2 PEO coatings was significantly higher (92% and 71%, respectively) than on the plasma-sprayed coating after 14 days. PEO has been demonstrated to be a promising method for coating of orthopedic implant surfaces.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ti-6Al-4V; collagen; hydroxyapatite; osteoblast; plasma electrolytic oxidation; plasma spraying

Mesh:

Substances:

Year:  2013        PMID: 23529912     DOI: 10.1002/jbm.b.32899

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  7 in total

1.  Effects of vitamin C on osteoblast proliferation and osteosarcoma inhibition using plasma coated hydroxyapatite on titanium implants.

Authors:  Naboneeta Sarkar; Hailey Morton; Susmita Bose
Journal:  Surf Coat Technol       Date:  2020-04-15       Impact factor: 4.158

2.  Biomimetic mineralized strontium-doped hydroxyapatite on porous poly(l-lactic acid) scaffolds for bone defect repair.

Authors:  Min Ge; Kun Ge; Fei Gao; Weixiao Yan; Huifang Liu; Li Xue; Yi Jin; Haiyun Ma; Jinchao Zhang
Journal:  Int J Nanomedicine       Date:  2018-03-20

Review 3.  Modifications of Dental Implant Surfaces at the Micro- and Nano-Level for Enhanced Osseointegration.

Authors:  In-Sung Luke Yeo
Journal:  Materials (Basel)       Date:  2019-12-23       Impact factor: 3.623

4.  Investigation of Biocompatible PEO Coating Growth on cp-Ti with In Situ Spectroscopic Methods.

Authors:  Veta Aubakirova; Ruzil Farrakhov; Arseniy Sharipov; Veronika Polyakova; Lyudmila Parfenova; Evgeny Parfenov
Journal:  Materials (Basel)       Date:  2021-12-21       Impact factor: 3.623

5.  Ultra-Porous Nanoparticle Networks: A Biomimetic Coating Morphology for Enhanced Cellular Response and Infiltration.

Authors:  Noushin Nasiri; Anthony Ceramidas; Shayanti Mukherjee; Anitha Panneerselvan; David R Nisbet; Antonio Tricoli
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

6.  Combining 3D human in vitro methods for a 3Rs evaluation of novel titanium surfaces in orthopaedic applications.

Authors:  G Stevenson; S Rehman; E Draper; E Hernández-Nava; J Hunt; J W Haycock
Journal:  Biotechnol Bioeng       Date:  2016-01-21       Impact factor: 4.530

7.  Characteristics and in vitro response of thin hydroxyapatite-titania films produced by plasma electrolytic oxidation of Ti alloys in electrolytes with particle additions.

Authors:  W K Yeung; I V Sukhorukova; D V Shtansky; E A Levashov; I Y Zhitnyak; N A Gloushankova; P V Kiryukhantsev-Korneev; M I Petrzhik; A Matthews; A Yerokhin
Journal:  RSC Adv       Date:  2016-02-01       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.